- Home
- WYY vs PYXS Comparison
WYY vs PYXS Comparison
Compare WYY & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYY | PYXS |
|---|---|---|
| Founded | 1991 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.2M | 71.6M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WYY | PYXS |
|---|---|---|
| Price | $5.83 | $1.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $8.67 | $6.75 |
| AVG Volume (30 Days) | 33.2K | ★ 1.2M |
| Earning Date | 11-13-2025 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $145,926,414.00 | $2,820,000.00 |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $15.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.62 | N/A |
| 52 Week Low | $2.19 | $0.83 |
| 52 Week High | $7.55 | $5.55 |
Technical Indicators
Market Signals| Indicator | WYY | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.37 | 40.43 |
| Support Level | $5.27 | $1.38 |
| Resistance Level | $7.06 | $1.64 |
| Average True Range (ATR) | 0.41 | 0.14 |
| MACD | -0.14 | 0.05 |
| Stochastic Oscillator | 30.63 | 25.24 |
Price Performance
Historical ComparisonAbout WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.